$2269 #WuXi Biologics (P Chip) Wuxi Biologics Cayman Inc : Turning challenges into opportunitie.: The Covid-19 pandemic caused delays in revenue booking in 1H20, but boosted services demand for WuXi Bio. By winning more new customers and… https://t.co/X4pUgC7VqA #equity #stocks https://t.co/fC2311mICt